Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Pradaxa – Oral Direct Thrombin Inhibitor



Risk of developing DVT or PE

Several factors can predispose people to increased risk of developing DVT or PE. Patients undergoing major orthopaedic surgery are at an especially high risk of developing venous thromboembolism.

  • human heart
    Venous thromboembolism is the third most common cardiovascular disease after...
  • Venous thromboembolism
    Venous thromboembolism can lead to deep vein thromboses and pulmonary embolisms.
  • Risk of developing DVT or PE
    Patients undergoing major orthopaedic surgery are at an especially high risk...
  • Oral anticoagulants
    In clinical use for some 50 years, the vitamin K antagonist warfarin remains...
  • Pradaxa (dabigatran etexilate)
    Pradaxa is a new oral anticoagulant under development by Boehringer Ingelheim.

Back to Project Details



Related Projects

Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for
Ariflo (cilomilast) is an oral selective phosphodiesterase (PDE) IV...

Sativex - Investigational Cannabis-Based treatment for Pain and Multiple Sclerosis
Developed by GW Pharmaceuticals, Sativex is a whole plant medicinal...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Acomplia (Rimonabant) - Investigational Agent for
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.